Filing Details
- Accession Number:
- 0001415889-21-001300
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 20:01:11
- Reporting Period:
- 2021-03-03
- Accepted Time:
- 2021-03-03 20:01:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591312 | I Bassil Dahiyat | C/O Xencor, Inc. 111 W. Lemon Ave Monrovia CA 91016 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-03 | 2,850 | $44.88 | 141,064 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 7,868 restricted stock units.
- The weighted average sale price for the transaction reported was $44.8803, and the range of prices were between $44.8801 and $45.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 232 shares acquired in June 2020 and 178 shares acquired in December 2020.
Billionaire Hedge Funds
